Maciej Banach
Medical University of Łódź
1071 Papers
4.4K Citations
Maciej Banach is an academic researcher from Medical University of Łódź. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 77, co-authored 905 publications. Previous affiliations of Maciej Banach include Esperion Therapeutics Inc. & Veterans Health Administration.
Chat about Author
Papers
Should we have any doubts about hypertension therapy in elderly patients?: ACCF/AHA 2011 expert consensus document on hypertension in the elderly.
Maciej Banach,Wilbert S. Aronow +1 more
TL;DR: The present article summarizes the most important issues discussed in the American College of Cardiology Foundation/American Heart Association 2011 Expert Consensus Document on Hypertension in the Elderly.
Predictors of paroxysmal atrial fibrillation in patients undergoing aortic valve replacement.
Maciej Banach,Aleksander Goch,Małgorzata Misztal,Jacek Rysz,Ryszard Jaszewski,Jan Henryk Goch +5 more
TL;DR: All patients should be preoperatively classified to applicable groups of risk of postoperative atrial fibrillation appearance, and the prophylactic treatment should be administered in the group of patients with the highest risk.
71
Menopause and women’s cardiovascular health: is it really an obvious relationship?
TL;DR: In this paper , the importance of the menopausal period as the time of increasing CVD risk was emphasized, and it was shown that women develop heart diseases later than men because of the protection in the reproductive phase of their life.
Detection of infectious agents by polymerase chain reaction in human aortic wall.
Edyta Reszka,Bogdan Jegier,Wojciech Wasowicz,Małgorzata Lelonek,Maciej Banach,Ryszard Jaszewski +5 more
TL;DR: Results demonstrate that C. pneumoniaE, M. pneumoniae, H. pylori, CMV, and HSV can be detected in macroscopically healthy aortic wall of coronary and valve patients in similar frequency, which do not support hypothesis concerning the role of microorganisms in atherosclerosis etiology.
70
Curcumin: An effective adjunct in patients with statin‐associated muscle symptoms?
TL;DR: Owing to the paucity of effective treatments, and the safety of curcumin in clinical practice, proof‐of‐concept trials are recommended to assess the potential benefit of this phytochemical in the treatment of SAMS.
70